Compugen Announces $15 Million Funding Agreement

[at noodls] – 20 November 2012 for Its Keddem Subsidiary Keddem’s unique technology platform focuses on small molecule drug discovery Tel Aviv, Israel – November 19, 2012 – Compugen Ltd. (Nasdaq: CGEN) announced today … more

View todays social media effects on CGEN

View the latest stocks trending across Twitter. Click to view dashboard